E-Therapeutics PLC (LON:ETX) says multiple proposals for its artificial intelligence-based drug research products have been sent to potential partners and customers.
Argentex Group PLC (LON:AGFX), the recently listed provider of foreign exchange services to institutions, corporates and high net worth private individuals, generated revenues of £9.3mln in just over three months since its AIM flotation.
Maxcyte Inc’s (LON:MXCT) technology for engineered cell mechanisms is to be used by Nasdaq-listed genome specialist Editas Medicine for diseases such as sickle cell anaemia and blood disorders.
Genedrive PLC (LON:GENE) has received approval from the NHS Health Research Authority to start testing its Antibiotic Induced Hearing (AIHL) test in hospital trials.
Real-time technologies company BATM Advanced Communications Limited (LON:BVC), has souped-up its cyber-security offering to make it compatible with devices using the Arm architecture.
Kalahari Metals Ltd, a company in which Metal Tiger Plc (LON:MTR) holds a 59.8% interest, has identified veinlet and disseminated sulphide copper mineralisation in drilling on its licences in Botswana.
Quadrise Fuels International PLC (LON:QFI) chairman Mike Kirk has, in its financial results statement, described “a hugely important year” for the company with significant progress made towards unlocking a broader range of opportunities.
Jersey Oil & Gas Plc (LON:JOG) has hired Rockflow Resources and Petrofac Facilities Management for services on the Greater Buchan Area development project.
i3 Energy Plc (LON:I3E) late in Friday’s session announced that drilling had begun for the Serenity appraisal well in the UK North Sea, the second in a series of three new wells being drilled by i3.